Cathie Biga, RN, MSN, discusses the importance of pre-planning for physician practices to avoid an audit. Having a full compliance plan for coding and documentation audits helps with appropriateness criteria, electronic medical record standards and making sure billing matches up with documentation. She also recommends that practices have at least one person who understands the MACRA legislation and shares the information with the entire group.

Cardiovascular providers discuss their biggest challenges, including payers refusing to cover tests, procedures or medications that could benefit patients and providing costly and beneficial therapies and procedures while dealing with cost constraints. There are plenty more, listen in.

Cardiologists J.P. Reilly, MD, and Larry S. Dean, MD, offer insight on the two-year results of the ABSORB III trial that evaluated Abbott’s Absorb bioresorbable vascular scaffold. They also talk about the March 18th FDA advisory letter alerting healthcare professionals of an increase in major adverse cardiac events with the Absorb compared with the Xience drug-eluting stent. As they note, physicians need to be careful about selecting the right patients who may benefit from bioresorbable stents, using them in right-sized vessels and making sure to properly deploy the devices.

Treating today’s cancer patient no longer means simply targeting the cancer. Given the known cardiotoxicities of some established chemotherapies and the possibility that newer approaches may damage the heart, oncologists, cardiologists and imaging specialists now work together to detect and minimize the risk of treatment-induced heart failure.

The approval of two new Current Procedural Terminology (CPT) codes acknowledges echocardiographic myocardial strain imaging and myocardial contrast perfusion echocardiography as emerging technologies, often a necessary step before a code is promoted to payable status.

Several medical societies recently released updated appropriate use criteria (AUC) for coronary revascularization in patients with acute coronary syndromes (ACS).

Professor William Wijns, co-director of EuroPCR and chairman of PCR, has joined NUI Galway as a professor of medical devices. He will head the $5 million research project to develop wearable sensors for patients at high risk of heart attacks.

New major recommendations for the use of surgical ablation in treating atrial fibrillation have been issued by the Society of Thoracic Surgeons Dec. 19 in an effort to improve surgical outcomes and the quality of patient care.